Samuel Fatoba

机构：Bayer (United States)

发表论文 41 篇 · 总被引 4684 次 · h-index 12

代表论文

• Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis (2022 · JAMA · 被引 189)
• Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020 (2023 · Diabetes Obesity and Metabolism · 被引 69)
• The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis (2023 · Nephrology Dialysis Transplantation · 被引 37)
• Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism (2023 · JACC CardioOncology · 被引 21)
• First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting (2024 · Journal of Nephrology · 被引 20)
• Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium (2023 · Nature Reviews Urology · 被引 11)